| Drug Name: | 3,4-Methylenedioxymethamphetamine (42542-10-9) |
|---|---|
| PubChem ID: | 1615 |
| SMILES: | CC(CC1=CC2=C(C=C1)OCO2)NC |
| InchiKey: | SHXWCVYOXRDMCX-UHFFFAOYSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 193.246 |
| LogP | : | 1.5657 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 3 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 30.49 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Ritonavir (155213-67-5) | Fatal Serotonergic Reaction | Antagonistic | Ritonavir inhibits the cytochrome P450 isoenzyme CYP2D6, which is responsible for the demethylenation of ecstasy, so concurrent use leads to a sharp rise in ecstasy plasma levels | A toxic interaction between mitomycin C and tamoxifen causing the haemolytic uraemic syndrome |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|